IBDEI0T8 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13444,1,3,0)
 ;;=3^Binocular Movement Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13444,1,4,0)
 ;;=4^H51.9
 ;;^UTILITY(U,$J,358.3,13444,2)
 ;;=^5006258
 ;;^UTILITY(U,$J,358.3,13445,0)
 ;;=H49.13^^80^760^19
 ;;^UTILITY(U,$J,358.3,13445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13445,1,3,0)
 ;;=3^Fourth Trochlear Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,13445,1,4,0)
 ;;=4^H49.13
 ;;^UTILITY(U,$J,358.3,13445,2)
 ;;=^5006186
 ;;^UTILITY(U,$J,358.3,13446,0)
 ;;=H47.013^^80^760^26
 ;;^UTILITY(U,$J,358.3,13446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13446,1,3,0)
 ;;=3^Ischemic Optic Neuropathy,Bilateral
 ;;^UTILITY(U,$J,358.3,13446,1,4,0)
 ;;=4^H47.013
 ;;^UTILITY(U,$J,358.3,13446,2)
 ;;=^5006107
 ;;^UTILITY(U,$J,358.3,13447,0)
 ;;=D86.82^^80^760^33
 ;;^UTILITY(U,$J,358.3,13447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13447,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,13447,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,13447,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,13448,0)
 ;;=H49.883^^80^760^38
 ;;^UTILITY(U,$J,358.3,13448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13448,1,3,0)
 ;;=3^Paralytic Strabismus,Bilateral
 ;;^UTILITY(U,$J,358.3,13448,1,4,0)
 ;;=4^H49.883
 ;;^UTILITY(U,$J,358.3,13448,2)
 ;;=^5006205
 ;;^UTILITY(U,$J,358.3,13449,0)
 ;;=H49.23^^80^760^44
 ;;^UTILITY(U,$J,358.3,13449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13449,1,3,0)
 ;;=3^Sixth Abducent Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,13449,1,4,0)
 ;;=4^H49.23
 ;;^UTILITY(U,$J,358.3,13449,2)
 ;;=^5006190
 ;;^UTILITY(U,$J,358.3,13450,0)
 ;;=H49.03^^80^760^48
 ;;^UTILITY(U,$J,358.3,13450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13450,1,3,0)
 ;;=3^Third Oculomotor Nerve Palsy,Bilateral
 ;;^UTILITY(U,$J,358.3,13450,1,4,0)
 ;;=4^H49.03
 ;;^UTILITY(U,$J,358.3,13450,2)
 ;;=^5006182
 ;;^UTILITY(U,$J,358.3,13451,0)
 ;;=H34.03^^80^760^51
 ;;^UTILITY(U,$J,358.3,13451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13451,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,13451,1,4,0)
 ;;=4^H34.03
 ;;^UTILITY(U,$J,358.3,13451,2)
 ;;=^5005555
 ;;^UTILITY(U,$J,358.3,13452,0)
 ;;=Z90.01^^80^761^1
 ;;^UTILITY(U,$J,358.3,13452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13452,1,3,0)
 ;;=3^Acquired Absence of Eye
 ;;^UTILITY(U,$J,358.3,13452,1,4,0)
 ;;=4^Z90.01
 ;;^UTILITY(U,$J,358.3,13452,2)
 ;;=^322068
 ;;^UTILITY(U,$J,358.3,13453,0)
 ;;=H04.552^^80^761^2
 ;;^UTILITY(U,$J,358.3,13453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13453,1,3,0)
 ;;=3^Acquired Stenosis of Left Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,13453,1,4,0)
 ;;=4^H04.552
 ;;^UTILITY(U,$J,358.3,13453,2)
 ;;=^5004539
 ;;^UTILITY(U,$J,358.3,13454,0)
 ;;=H04.551^^80^761^3
 ;;^UTILITY(U,$J,358.3,13454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13454,1,3,0)
 ;;=3^Acquired Stenosis of Right Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,13454,1,4,0)
 ;;=4^H04.551
 ;;^UTILITY(U,$J,358.3,13454,2)
 ;;=^5004538
 ;;^UTILITY(U,$J,358.3,13455,0)
 ;;=H01.115^^80^761^4
 ;;^UTILITY(U,$J,358.3,13455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13455,1,3,0)
 ;;=3^Allergic Dermatitis of Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,13455,1,4,0)
 ;;=4^H01.115
 ;;^UTILITY(U,$J,358.3,13455,2)
 ;;=^5133386
 ;;^UTILITY(U,$J,358.3,13456,0)
 ;;=H01.114^^80^761^5
 ;;^UTILITY(U,$J,358.3,13456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13456,1,3,0)
 ;;=3^Allergic Dermatitis of Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,13456,1,4,0)
 ;;=4^H01.114
 ;;^UTILITY(U,$J,358.3,13456,2)
 ;;=^5004256
